GLP-1 telehealth vs going through my own doctor: which is better?

The better option depends entirely on your specific health profile: telehealth is ideal for low-risk patients (BMI 27–30, no comorbidities, existing primary care), while in-person care is superior for complex cases (BMI ≥ 35, multiple comorbidities, or cardiovascular disease) due to the critical value of physical examination and real-time monitoring [1].

When Telehealth GLP-1 is Better

Choose a reputable telehealth platform (like Meto or Ro) if you fit these criteria:

• Low Clinical Complexity: You are under 40, have a BMI between 27–30, and no significant comorbidities [1].
• Existing Primary Care: You already have a primary care provider (PCP) managing your other health needs [1].
• Geographic or Cost Barriers: Distance from in-person clinics is a genuine logistical barrier, or budget is the limiting factor (telehealth with compounded meds is often cheaper than branded in-person options) [1][7].
• Convenience: You prioritize fast access and streamlined onboarding over physical exams [1].

Recommended Telehealth Brands:

• Meto: The only platform in recent comparisons that meets the full clinical standard (requires baseline labs, assigns metabolic specialists, accepts insurance with $0–$50 copays, and provides ongoing monitoring) [2].
• Ro: More flexible than Hims but inconsistent on labs; a good middle ground for those wanting insurance support [2].
• Hims & Hers: Best for fastest access to branded meds (Wegovy, Zepbound) with insurance, but no clinical monitoring; appropriate only if you have recent normal labs from another provider [2].

When In-Person (Your Own Doctor) is Better

Choose your Primary Care Physician (PCP) or an in-person specialist if you fit these criteria:

• High Clinical Stakes: You have a BMI ≥ 35, multiple comorbidities, or established cardiovascular/metabolic disease [1].
• Need for Physical Exam: Telehealth does not include abdominal palpation, lymph node assessment, blood pressure measurement, heart sound evaluation, or grip strength assessment [1]. These are essential for patients with complex regimens or prior discontinued therapy [1].
• Complex Medication Regimens: If you are on multiple medications, in-person continuity and real-time monitoring produce better outcomes [1].
• Prior Therapy Failure: If you have tried and discontinued GLP-1 therapy before, in-person care is more likely to succeed [1].

Key Difference: The core question is not "which provider is better abstractly," but "which provider monitors you as a real patient?" Many telehealth platforms (like Hims) prescribe quickly but never check in, whereas platforms like Meto or in-person doctors provide the rigorous monitoring required for safety [2].

Final Recommendation

• If you are low-risk (BMI < 30, no health issues): Go with Meto for telehealth. It offers the clinical rigor of in-person care (labs, specialists, monitoring) with the convenience and cost benefits of telehealth [2].
• If you are high-risk (BMI > 35, health issues): Stick with your own doctor (PCP). The ability to perform a physical exam and manage complex interactions is non-negotiable for your safety [1].
• Hybrid Approach: Some patients use telehealth for the medication (to access bulk discounts) while keeping their PCP for medical guidance and monitoring [7].

Always consult a licensed provider to determine appropriateness for your individual needs before starting [4].

Summary Comparison:

Bottom Line: If you are low-risk, Meto is the top telehealth choice for safety and monitoring [2]. If you have complex health needs, your own doctor is the only safe option [1].